CRO #1

• Built first “in-country” ECG cardiac safety lab for clinical trials in their home market
• Successfully attained US, EU and Latin American Regulatory approval for clinical trial lab in their home market
• Achieved year-over-year sales growth of 40%
• 300% increase in new clinical study wins in year 1 -> year 2

CRO #2

• Led acquisition efforts in the US and EU
• Secured strategic partnership agreements with two US academic research centers
• Established regional CRO partnerships in Australia, Asia, Russia and Eastern Europe
• Established US capabilities to drive marketing, brand awareness and sales efforts

• Conducted and completed a corporate wide due diligence effort over a 4-day period
• Submitted a report of findings and recommendations to the BoD within 48-hrs
• Joined the company at the request of the BoD to execute the proposed plan
• Plan included:
  • 30% decrease in SG&A
  • Redefine business strategy
  • Orderly closure of two facilities
  • Filing Chapter 11
  • Restructuring the company
• Retained 100% of customers and venders
• Within 30-days, initiated three new work streams to move the company forward
• Within 90-days had signed LOIs and APAs from investors to purchase all or parts of the business

• Conducted and completed a corporate wide due diligence effort over a 30-day period
• Created a step-wise plan to correct major problems immediately while restructuring the core business
• Joined the company at the request of the BoD to execute the proposed plan
• Plan included:
  • 30% decrease in SOPs
  • Redefine operational staffing and line management strategy
  • Restructuring the entire business unit
  • Redefining performance metrics and reward mechanisms
  • Creating new project staffing models
• Decreased annualize staff attrition to 12% within 12-months
• Increased revenue to $330MM in 18-months; becoming the most profitable Business Unit in the company
• Improved quality and customer satisfaction by 88% within 12-months
• Improved customer repeat business from 63% to 97% in 12-months

• Grew annual revenue from $38MM to $58MM in 2-yrs
• Turned EBITDA from -$3MM to +$2MM in 2-yrs
• Rebuilt BD, Operations, Quality teams
• Sold company to a strategic buyer in a 90-day sale process
• Owner shares went from “under water” to a positive ROI

• Conducted global market research to establish competitive landscape
• Created all business processes, marketing materials, develop both businesses
• BD team and hired a team globally to Established core business operative offices in the US, EU, South Africa, India, Singapore and Japan
• Launched both lines of business and grew them to $17MM in annual revenue in 2-yrs

• Identified three CROs for acquisition, 2 in the US, 1 in EU with operations in the US, UK, France, Croatia and Australia
• Complete acquisition and integration of all 3 CROs; re-launched a single re-branded international CRO
• Grew business 22% in 18-months with a contribution margin of 18%
• Successfully sold the business to a strategic buyer within 120-days